Allele specific PCR for a major marker of levamisole resistance in Haemonchus contortus.
Allele specific PCR
Diagnostic
Haemonchus
Levamisole
RFLP
Resistance
S168T
SNP
Journal
International journal for parasitology. Drugs and drug resistance
ISSN: 2211-3207
Titre abrégé: Int J Parasitol Drugs Drug Resist
Pays: Netherlands
ID NLM: 101576715
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
11
04
2022
revised:
04
08
2022
accepted:
04
08
2022
pubmed:
16
8
2022
medline:
15
12
2022
entrez:
15
8
2022
Statut:
ppublish
Résumé
Haemonchus contortus is a haematophagous parasitic nematode that infects small ruminants and causes significant animal health concerns and economic losses within the livestock industry on a global scale. Treatment primarily depends on broad-spectrum anthelmintics, however, resistance is established or rapidly emerging against all major drug classes. Levamisole (LEV) remains an important treatment option for parasite control, as resistance to LEV is less prevalent than to members of other major classes of anthelmintics. LEV is an acetylcholine receptor (AChR) agonist that, when bound, results in paralysis of the worm. Numerous studies implicated the AChR sub-unit, ACR-8, in LEV sensitivity and in particular, the presence of a truncated acr-8 transcript or a deletion in the acr-8 locus in some resistant isolates. Recently, a single non-synonymous SNP in acr-8 conferring a serine-to-threonine substitution (S168T) was identified that was strongly associated with LEV resistance. Here, we investigate the role of genetic variation at the acr-8 locus in a controlled genetic cross between the LEV susceptible MHco3(ISE) and LEV resistant MHco18(UGA2004) isolates of H. contortus. Using single worm PCR assays, we found that the presence of S168T was strongly associated with LEV resistance in the parental isolates and F3 progeny of the genetic cross surviving LEV treatment. We developed and optimised an allele-specific PCR assay for the detection of S168T and validated the assay using laboratory isolates and field samples that were phenotyped for LEV resistance. In the LEV-resistant field population, a high proportion (>75%) of L
Identifiants
pubmed: 35970104
pii: S2211-3207(22)00018-5
doi: 10.1016/j.ijpddr.2022.08.001
pmc: PMC9399269
pii:
doi:
Substances chimiques
Levamisole
2880D3468G
Anthelmintics
0
Receptors, Cholinergic
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17-26Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T020733/1
Pays : United Kingdom
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors report that they have no conflict of interest.